Cannabis stocks rallied on Friday on reports that the MORE Act will get a hearing on Monday in the House Rules Committee, the final step before it can come to a vote on the House floor. The MORE Act would de-schedule cannabis and give the legalization the industry in the US has been pushing for. It last passed the House in December, 2020, but failed to receive a vote in the then-Republican controlled Senate.
Most industry experts believe passage again in the House is likely, but they continue to believe it is unlikely to pass the Senate in its current form. It still requires 60 votes in the Senate, a level of support that experts do not believe it has. Even among Democrats, Sens. Tester and Shaheen have spoken out against cannabis legalization, suggesting that the rally in cannabis stocks on Friday was premature.